Dr. John Reneau, MD,PhD
Claim this profileOhio State University Wexner Medical Center
Studies Lymphoma
Studies Mixed-Cell Lymphoma
2 reported clinical trials
3 drugs studied
Area of expertise
1Lymphoma
Stage II
Stage I
Stage III
2Mixed-Cell Lymphoma
Stage II
Stage I
Stage III
Affiliated Hospitals
More about John Reneau, MD,PhD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments John Reneau, MD,PhD has experience with
- Brentuximab Vedotin
- Lenalidomide
- KT-333
Breakdown of trials John Reneau, MD,PhD has run
Lymphoma
Mixed-Cell Lymphoma
T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Anaplastic Large Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does John Reneau, MD,PhD specialize in?
Is John Reneau, MD,PhD currently recruiting for clinical trials?
Are there any treatments that John Reneau, MD,PhD has studied deeply?
What is the best way to schedule an appointment with John Reneau, MD,PhD?
What is the office address of John Reneau, MD,PhD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.